Month: March 2024
2071 posts
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery
TAIPEI, March 5, 2024 /PRNewswire/ — Taiwan-based Formosa Pharmaceuticals (6838.TWO) and AimMax…